Common use of Compliance Program Clause in Contracts

Compliance Program. The Company has taken such steps as the Company, believes are reasonable and appropriate to comply in all material respects with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or EMA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.

Appears in 6 contracts

Samples: Sales Agreement (Actinium Pharmaceuticals, Inc.), Original Sales Agreement (Actinium Pharmaceuticals, Inc.), Sales Agreement (Actinium Pharmaceuticals, Inc.)

AutoNDA by SimpleDocs

Compliance Program. The Company has taken such steps as the Company, Company believes are reasonable and appropriate to comply in all material respects with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority having jurisdiction over the Company and performing functions similar to those performed by the FDA or EMA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.

Appears in 4 contracts

Samples: NeuroMetrix, Inc., NeuroMetrix, Inc., NephroGenex, Inc.

Compliance Program. The Company has and its Subsidiaries have taken such steps as the Company, believes are reasonable and appropriate to comply in all material respects with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority having jurisdiction over the Company and its Subsidiaries and performing functions similar to those performed by the FDA or EMA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.

Appears in 3 contracts

Samples: Underwriting Agreement (Forte Biosciences, Inc.), Forte Biosciences, Inc., Forte Biosciences, Inc.

Compliance Program. The Company has taken such steps as the Company, Company believes are reasonable and appropriate to comply in all material respects with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority having jurisdiction over the Company and performing functions similar to those performed by the FDA or EMA); except where such noncompliance would not be reasonably be expected to have a Material Adverse Effect.

Appears in 2 contracts

Samples: Spectrum Pharmaceuticals Inc, Spectrum Pharmaceuticals Inc

AutoNDA by SimpleDocs

Compliance Program. The Company has taken such steps as the Company, Company believes are reasonable and appropriate to comply in all material respects with applicable regulatory guidelines (including, without limitation, those administered by the FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA or EMA); except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.

Appears in 2 contracts

Samples: Sales Agreement (Kalobios Pharmaceuticals Inc), InspireMD, Inc.

Time is Money Join Law Insider Premium to draft better contracts faster.